Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Greiner

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 10, 1995
Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligandD C Parker, D L Greiner, N E Phillips, et al.
The American Journal of Pathology|April 1, 1995
Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid miceD L Greiner, L D Shultz, J Yates, et al.
Journal of Autoimmunity|October 1, 1991
Islet cells but not thyrocytes are susceptible to lysis by NK cellsY Kitagawa, D L Greiner, C W Reynolds, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2007
Different mechanisms control peripheral and central tolerance in hematopoietic chimeric miceM Yamazaki, T Pearson, M A Brehm, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1997
Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid miceS W Christianson, D L Greiner, R A Hesselton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatmentX X Zheng, T G Markees, W W Hancock, et al.
Clinical and Experimental Immunology|September 13, 2008
Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftmentT Pearson, L D Shultz, D Miller, et al.
Gene Therapy|October 19, 2012
Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivoN A McNeer, E B Schleifman, A Cuthbert, et al.
Cell Transplantation|March 7, 1998
Blockade of CD40-CD154 interferes with human T cell engraftment in scid miceT M Foy, M McIlraith, S R Masters, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 29, 2000
NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cellsL D Shultz, P A Lang, S W Christianson, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Proceedings of the National Academy of Sciences of the United States of America|October 10, 1995
Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligandD C Parker, D L Greiner, N E Phillips, et al.
The American Journal of Pathology|April 1, 1995
Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid miceD L Greiner, L D Shultz, J Yates, et al.
Journal of Autoimmunity|October 1, 1991
Islet cells but not thyrocytes are susceptible to lysis by NK cellsY Kitagawa, D L Greiner, C W Reynolds, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2007
Different mechanisms control peripheral and central tolerance in hematopoietic chimeric miceM Yamazaki, T Pearson, M A Brehm, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1997
Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid miceS W Christianson, D L Greiner, R A Hesselton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatmentX X Zheng, T G Markees, W W Hancock, et al.
Clinical and Experimental Immunology|September 13, 2008
Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftmentT Pearson, L D Shultz, D Miller, et al.
Gene Therapy|October 19, 2012
Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivoN A McNeer, E B Schleifman, A Cuthbert, et al.
Cell Transplantation|March 7, 1998
Blockade of CD40-CD154 interferes with human T cell engraftment in scid miceT M Foy, M McIlraith, S R Masters, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 29, 2000
NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cellsL D Shultz, P A Lang, S W Christianson, et al.
Pageof 16